GlassScriptPhysician profile
Bernard Tekiele
NPI 1609879741
$6,262.26
in general payments reported to CMS, 2019-2025
20 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $338 · 2021: $780 · 2022: $1,235 · 2023: $283 · 2024: $741 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,505.18 | 2019-2025 | Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $1,288.69 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $495.64 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $396.22 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $341.29 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $324.60 | 2021-2022 | |
| Rxsight INC | $314.55 | 2021-2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $269.01 | 2019-2021 | |
| Biotissue Holdings INC. | $216.96 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $205.55 | 2023-2024 | Xiidra, Miebo, Envista Mx60 Iol |
| Sight Sciences, INC. | $163.38 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $156.08 | 2019-2022 | |
| Beaver-Visitec International, INC. | $121.25 | 2022 | |
| Allergan, INC. | $99.06 | 2020-2022 | |
| Coopervision INC. | $89.19 | 2024 | Myday Contact Lens |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $88.19 | 2022-2025 | Durysta |
| Optos, INC. | $70.57 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $48.48 | 2022-2023 | Omidria, Rayone Spheric, Rayone Emv |
| Ocular Therapeutix, INC. | $34.54 | 2022 | |
| Carl Zeiss Meditec, INC. | $33.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Tekiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.